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Abstract
Background: Fusarium species are widely spread in nature as plant pathogens but are also able to cause
opportunistic fungal infections in humans. We report a cluster of Fusarium oxysporum bloodstream infections in a
single pediatric cancer center.
Methods: All clinical and epidemiological data related to an outbreak involving seven cases of fungemia by
Fusarium oxysporum during October 2013 and February 2014 were analysed. All cultured isolates (n = 14) were
identified to species level by sequencing of the TEF1 and RPB2 genes. Genotyping of the outbreak isolates was
performed by amplified fragment length polymorphism fingerprinting.
Results: In a 5-month period 7 febrile pediatric cancer patients were diagnosed with catheter-related Fusarium
oxysporum bloodstream infections. In a time span of 11 years, only 6 other infections due to Fusarium were
documented and all were caused by a different species, Fusarium solani. None of the pediatric cancer
patients had neutropenia at the time of diagnosis and all became febrile within two days after catheter
manipulation in a specially designed room. Extensive environmental sampling in this room and the hospital
did not gave a clue to the source. The outbreak was terminated after implementation of a multidisciplinary
central line insertion care bundle. All Fusarium strains from blood and catheter tips were genetically related
by amplified fragment length polymorphism fingerprinting. All patients survived the infection after prompt
catheter removal and antifungal therapy.
Conclusion: A cluster with, genotypical identical, Fusarium oxysporum strains infecting 7 children with cancer,
was most probably catheter-related. The environmental source was not discovered but strict infection control
measures and catheter care terminated the outbreak.
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invasive fungal infections
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Background
Due to prolonged survival of patients with cancer, inva-
sive fungal diseases (IFD) emerged as important cause of
morbidity and mortality. In pediatric cancer patients,
Candida species remain as the most important cause of
IFD followed by invasive infections by Aspergillus spp.
and other moulds [1–3].
Epidemiology of fungal infections varies markedly ac-
cording to the geographic region. In Brazil, Fusarium spp.
infections have emerged as major pathogens of systemic
infections among cancer patients [4]. Fusarium species
are widely spread in nature as plant pathogens and are
also able to cause superficial, locally invasive and dissemi-
nated infections in humans [5]. Infection occurs mainly
through airborne transmission, skin breakdown due to
trauma, burns or insertion of vascular catheters [6, 7]. The
clinical presentation relies mostly on the hosts’ immune
status, with disseminated infections been reported espe-
cially in severe immunocompromised individuals leading
to high mortality rates [6, 8].
The lack of data concerning the epidemiology and
clinical aspects of invasive infections by Fusarium spp.
in pediatric patients is notable. Here we report a cluster
of Fusarium oxysporum bloodstream infections from
seven pediatric cancer patients documented in a single
Brazilian pediatric cancer center.
Methods
We retrospectively studied all clinical and epidemio-
logical data related to an outbreak enrolling seven cases
of fungemia by Fusarium oxysporum occurring between
October 2013 and February 2014 in the Pediatric Oncol-
ogy Institute (IOP), located in Sao Paulo, Brazil. IOP is a
tertiary care hospital specialized in pediatric oncology
which admits 300 new cases per year. The outbreak was
documented in patients who had been treated with
chemotherapy at the same room used for cancer ambu-
latory chemotherapy. All long-term intravascular cathe-
ters are implanted in the surgery room and cared for by
a group of trained nurses.
Clinical and epidemiological data were collected by a
single investigator who reviewed all electronic medical
records in order to complete a clinical form including
information related to gender, age, underlying diseases,
presence of neutropenia, exposition to invasive medical
procedures and immunosuppressive drugs, imaging, cul-
ture results, treatment and clinical outcome.
During the outbreak, all catheters were removed and cul-
tured in accordance with procedures standardized in our
division based on cultures of catheter tips and material in-
side the reservoir. A cut-off of ≥103 CFU/plate was used to
differentiate significant from insignificant colonization as
suggested by Brun–Buisson et al. [9, 10]. All patients were
screened for putative deep-seated infection by sinus and
chest CT as well as echocardiography and eye fundoscopy.
After the diagnosis of fusariosis, at least two serum samples
were collected from each patient to check for galactoman-
nan levels and patients were followed for another 90 days
for clinical signs and symptoms.
Laboratory procedures
Isolates
All Fusarium spp. cultured from blood and catheter sam-
ples (swab, flush and tip) were initially identified by mor-
phological characteristics [11] and further identified to
species level by sequencing TEF1 and RPB2 genes [12].
Besides clinical strains, we cultured environmental
samples including air-filters, tap water samples, swab of
room surfaces, and different intravenously administered
drugs [13, 14]. We finally also evaluated all health care
workers for the presence of onychomycosis or other
superficial fungal infections.
Molecular identification of Fusarium isolates
Genomic DNA of all Fusarium isolates was extracted with
the PrepMan Ultra Sample Preparation Reagent kit (Ap-
plied Biosystems, Palo Alto, CA, USA) according to the
manufacturer’s instructions. PCRs were performed for the
amplification of the largest subunit of RNA polymerase
(RPB2) and the translation elongation factor-1α (TEF1α)
following the methods published by Salah et al. [15]. The
primer pairs for TEF1α were EF1 & EF2 [16] and for
RPB2 were RPB2-7cR & RPB2 -5F [17]. PCR products
were sequenced with the same primers used for amplifica-
tion. The ABI Prism® Big DyeTM Terminator v. 3.0 Ready
Reaction Cycle Sequencing Kit (Applied Biosystems) was
used for sequencing PCR according to the manufacturer’s
instructions. The samples were run on an ABI 3730XL
automatic sequencer (Applied Biosystems). A BLAST
search of TEF1 and RPB2 sequences against the database
FUSARIUM-ID (http://isolate.fusariumdb.orgl/), the Fu-
sarium database (http://www.cbs.knaw.nl/fusarium) and
GenBank databases (www.ncbi.nlm.nih.gov) were used as
an initial step to identify isolates to species and/or species
complex. The TEF1 and RPB2 nucleotide sequences of all
isolates were deposited in GenBank.
Amplified fragment length polymorphism
Amplified fragment length polymorphism (AFLP) finger-
printing was performed as described recently [18]. Briefly,
~50 ng of genomic DNA was digested by using the Hpy-
CH4IV and MseI restriction enzymes (New England Bio-
labs, Ipswich, MA, U.S.A.) and in the same reaction specific
adaptors were ligated to each of the two sticky ends of the
DNA fragments. The samples were after a 1 h incubation
at room temperature diluted with 10 mM Tris-HCl, 1.0 μl
of this diluted product was used as input for the PCR that
contains the selective primers HpyCH4IV-C (5′-Flu-
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GTAGACTGCGTACCCGTAC-3′) and MseI-TGAG (5′-
GATGAGTCCTGACTAATGAG). After the PCR was per-
formed, the amplicons were 20× diluted using ddH2O and
1.0 μl of it was mixed with 8.9 μl ddH2O and 0.1 μl LIZ600
internal size marker (Promega, Leiden, The Netherlands)
followed by a heating step for 1 min at 100 °C. Fragment
analysis was performed on an ABI3500xL Genetic Analyzer
(Applied Biosystems, Foster City, CA, U.S.A.) according to
the manufacturer’s instructions. Subsequently, the raw data
was imported into Bionumerics v7.5 (Applied Maths, Sint
Martems-Latum, Belgium), after processing the data a den-
drogram was generated by using the UPGMA algorithm.
Results
From October 2013 to February 2014 we were caught by
surprise with the occurrence of seven episodes of micro-
biologic documented catheter-related F. oxysporum
bloodstream infections (CR-BSI) in our division. This
finding led us to believe that we were facing an outbreak
because only six cases of invasive fusariosis had been di-
agnosed in our hospital in the 11 years previously, all
caused by Fusarium solani species complex strains.
Demographic and clinical data of all seven patients are
depictured in Table 1. Ages ranged from 0 to 8 years (3
males), 6 out 7 were treated with chemotherapy for solid
tumors, and one for acute lymphoid leukemia (ALL). Two
patients (solid tumors) had underwent an autologous stem
cell transplantation more than 14 days before and none of
the patients received corticosteroids or other immunosup-
pressive agents. Only one patient had a neutrophil count
below 500 cells/mm3 at the moment of the infection.
Fever was the only trigger to collect blood cultures and
vascular catheters were removed promptly at the time
fungemia was identified. The six intravascular devices re-
moved included 5 totally surgically implanted (Porth-a-
Cath) catheters and one peripherally inserted catheter
(PICC). All fungemic episodes were documented following
2 days after the last catheter puncture by the nurse. No
single patient had any additional skin breakdown or ony-
chomycosis that could explain the portal of entrance for
Fusarium spp. All catheter tips, reservoir and blood cul-
tures collected through the CVC of the 7 patients yielded
Fusarium oxysporum. Although they had no signs or
symptoms of any organ involvement, further laboratorial
investigation was conducted to exclude fungal invasion of
target organs. All children had a chest computer tomog-
raphy (CT), sinus magnetic resonance image, eye fundos-
copy and echocardiography done without any evidence of
a deep-seated fungal infection. All serum samples were
galactomannan negative. Catheters were promptly re-
moved after blood cultures became positive and all pa-
tients had good clinical response to antifungal therapy.
Oral voriconazole was the therapy of choice for six pa-
tients (7 mg/kg/dose) and adequate serum levels (≥1 mg/
L) were measured in all patients. One child was treated
with liposomal amphotericin B (5 mg/kg/day) due to age
restrictions (9 months) for using voriconazole.
It is important to note that during the whole period
this cluster occurred, the hospital building was being en-
larged, counting with an extensive construction area.
All environmental samples and different intravenous
preparations in search for sources of Fusarium spp. were
negative. Healthcare workers who had previous contact
with the patients were checked for the presence of any
cutaneous or nail lesions suggestive of fungal infections
but nothing was found.
Molecular identification of Fusarium isolates
A total of 16 Fusarium spp. clinical isolates were identi-
fied to genus level by colony and microscopic character-
istics of the isolates. Upon molecular identification,
based on TEF1 and RPB2 partial genes analysis, all Fu-
sarium isolates were found to be members of the F. oxy-
sporum species complex. All environmental samples
were culture negative.
A phylogenetic tree (Additional file 1: Figure S1) was
constructed with a total of 20 sequences for two genes,
with three strains from the Fusarium solani species com-
plex (FSSC) i.e. F. falciforme (NRRL32542), F. keratoplasti-
cum (FRC-S2477) and F. petroliphilum (NRRL32856) as
outgroup. The generated tree was separated into two
clades. Clade 1 included all members of the F. oxysporum
species complex (FOSC) and clade 2 represented the F.
solani species complex (FSSC), the final result of the iden-
tification process was that 16 isolates were confirmed as
members of FOSC.
Typing results by amplified fragment length
polymorphism
All Fusarium strains obtained from blood and catheter
tips were considered genetically related by AFLP finger-
printing, suggesting that all isolates had a common
source. Cluster analysis revealed the presence of two
clusters, one with a 95% similarity that includes isolates
BRAZIL 1127 (Patient 2 catheter tip culture), 1129 (Pa-
tient 2 reservoir culture), 1131 (Patient 2 blood culture)
and 1134 (Patient 3 catheter tip culture), and a second
one with all other Brazilian isolates that exhibited simi-
larity of 97% (Fig. 1). The reference F. oxysporum isolates
CBS192.31 and CBS180.29, had a similarity of 90% and
80%, respectively, to the Brazilian isolates.
Discussion
In Brazil, invasive fusariosis is the most common cause
of systemic mould infections in hematologic cancer pa-
tients [4] and has been associated with a poor prognosis
[19]. There is a gap in knowledge with regard to the epi-
demiology of fusariosis in pediatric patients. Most papers
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represent single case reports, with the exception of two
outbreaks that were also documented in Brazilian
medical centers and a review paper [20–22]. Information
provided by the largest pediatric series of fusariosis
published in the medical literature shows that the most
common underlying condition was leukemia. Lung,
blood and skin were the most commonly reported sites
of infection and mortality rates are usually higher than
50% [22].
There is a consensus in the literature that the respira-
tory tract is the main portal of entry for this fungal in-
fection, followed by skin breakdown due trauma and/or
burns [23–31]. Despite some reports suggesting that
fusariosis may also be acquired by contamination of a
central venous catheter, the real prevalence and the nat-
ural history of intravascular catheter related fusariosis
remains unclear [32–36].
Velasco and colleagues reported four immunocom-
promised children between 4 and 12 years, having neuro-
blastoma (n = 1) or hematologic malignancies (n = 3) who
developed catheter-related Fusarium spp. infections with-
out neutropenia. Fungemia was followed by skin lesions in
only one patient and there was no clinical or radiological
evidence of respiratory tract involvement. All patients sur-
vived after cathether removal and treatment with conven-
tional amphotericin B [21].
Recently, Colombo et al. [35] described a case of a 13-
year-old boy in Italy diagnosed with ALL readmitted 1
month after the start of chemotherapy due to intermit-
tent fever of unknown origin, without any clinical or
radiological evidence of invasive infection. Patient had
his Broviac central venous catheter removed and blood
cultures taken from the CVC were positive only for F.
solani species complex. In addition, scanning electron
microscopy of the catheter tip demonstrated the forma-
tion of a large mycelium in the catheter lumen that
yielded a positive culture of F. solani complex. This find-
ing represents a strong support for the hypothesis that
fungemia was related to fungal colonization of the cath-
eter. Fungemia resolved without any evidence of deep-
seated infection after prompt CVC removal and therapy
with voriconazole.
We report an outbreak of F. oxysporum infection enrol-
ling 6 children with solid cancers and one with ALL in
complete remission without persistent neutropenia. Fever
was the only clinical manifestation of infection and the
trigger to collect blood cultures in all episodes. Patients
were carefully examined, and no single event of fungal
deep tissue infection was documented. Finally, in the ab-
sence of respiratory infection as well as any type of skin
breakdown that could be the port of entry, we are con-
vinced that the intravascular catheter was the source of all
episodes of F. oxysporum. Indeed, by typing all isolates
with AFLP we confirmed our hypothesis that the 7 cases
of F oxysporum were related, and all cultures of catheter
tips and reservoirs had similar or identical genotypes to
isolates obtained from blood cultures. Because all environ-
mental investigations were negative for the presence of
Fusarium spp., we were not able to identify the presumed
common source of all infections. On the other hand, we
may not exclude the possibility that medical devices were
colonized by Fusarium during inappropriate management
of intravascular catheters by health care workers or by the
contamination of intravascular fluids.
Disseminated fusariosis is a difficult to treat fungal in-
fection with an overall mortality ranging between 50% and
80% mostly due to uncontrolled hematologic malignant
disease, prolonged neutropenia and the exposition to cor-
ticosteroids [19, 37]. Indeed, during a recent outbreak
among children with cancer, fungemia and deep-seated in-
fections due to Fusarium the mortality rate was 50% [20].
In contrast, in the present series, and as documented
by previous reports of catheter related fusariosis [21, 33],
we observed a complete clinical recovery of all patients
after removal of the intravascular catheter and initiation
of appropriate antifungal therapy. The good outcome
Fig. 1 AFLP fingerprint analysis was performed on 16 clinical Fusarium oxysporum species complex isolates. The dendrogram was generated by
using the Pearson correlation similarity coefficient followed by single linkage cluster analysis
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documented with our patients may be explained also be-
cause there was no neutropenia or exposition to cortico-
steroids at the time they developed fusariosis.
F. oxysporum was the etiologic agent responsible for
all fungemias documented in the present outbreak. This
finding is in accordance with previous reports where
seven out ten cases of Fusarium spp. fungemias and
intravascular catheter related infections were due non-
solani Fusarium species [21, 23, 33–36, 38].
Measures taken to control the outbreak were lowering
the level of humidity in the CVC storage room and the im-
plementation of a multidisciplinary quality-improvement
intervention, including a central line insertion care bundle,
consisting of hand hygiene, maximal sterile barrier use
upon insertion and use of chlorhexidine skin disinfection.
After the introduction of these actions, no further cases
were noted.
In conclusion, Fusarium fungemia may be acquired by
intravascular catheter colonization without any further
deep-seated infections. In case of Fusarium outbreaks, es-
pecially involving non-F. solani species, clinicians should
be aware that contamination of central venous catheter
may be the potential source of infection.
Conclusions
We described 7 episodes of Fusarium oxysporum fun-
gemia where we presented strong clinical and labora-
torial documentation supporting the hypothesis that
the portal of entry for all cases of fusariosis was the
intravascular central catheter. In case of Fusarium
outbreaks, especially involving non-F. solani species,
clinicians should be aware that contamination of cen-
tral venous catheter may be a potential source. Fi-
nally, we added information suggesting that the
clinical outcome of catheter related fungemia due to
Fusarium may be favorable in patients without neu-
tropenia who were submitted to prompt CVC re-
moval and early initiation of antifungal therapy.
Additional file
Additional file 1: Figure S1. Phylogenetic tree resulting from RAxML
analysis for the RPB2 and TEF1genes (values of 85% for maximum
likelihood are shown). List of the 16 isolates examined in this study
(Brazil) and controls. (TIFF 330 kb)
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